List of Excipients in API fosdenopterin hydrobromide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing fosdenopterin hydrobromide
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Sentynl Therapeutics Inc | NULIBRY | fosdenopterin hydrobromide | 42358-295 | ASCORBIC ACID | 2028-02-26 |
Sentynl Therapeutics Inc | NULIBRY | fosdenopterin hydrobromide | 42358-295 | HYDROCHLORIC ACID | 2028-02-26 |
Sentynl Therapeutics Inc | NULIBRY | fosdenopterin hydrobromide | 42358-295 | MANNITOL | 2028-02-26 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for fosdenopterin hydrobromide
Excipient focus: ASCORBIC ACID
fosdenopterin hydrobromide drug variants containing ASCORBIC ACID
Company | Ingredient | NDC |
---|---|---|
Sentynl Therapeutics Inc | fosdenopterin hydrobromide | 42358-295 |
Origin Biosciences Inc | fosdenopterin hydrobromide | 73129-001 |
>Company | >Ingredient | >NDC |
fosdenopterin hydrobromide drug variants not containing ASCORBIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
fosdenopterin hydrobromide drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Sentynl Therapeutics Inc | fosdenopterin hydrobromide | 42358-295 |
Origin Biosciences Inc | fosdenopterin hydrobromide | 73129-001 |
>Company | >Ingredient | >NDC |
fosdenopterin hydrobromide drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
fosdenopterin hydrobromide drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Sentynl Therapeutics Inc | fosdenopterin hydrobromide | 42358-295 |
Origin Biosciences Inc | fosdenopterin hydrobromide | 73129-001 |
>Company | >Ingredient | >NDC |
fosdenopterin hydrobromide drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
fosdenopterin hydrobromide drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Sentynl Therapeutics Inc | fosdenopterin hydrobromide | 42358-295 |
Origin Biosciences Inc | fosdenopterin hydrobromide | 73129-001 |
>Company | >Ingredient | >NDC |
fosdenopterin hydrobromide drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
fosdenopterin hydrobromide drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Sentynl Therapeutics Inc | fosdenopterin hydrobromide | 42358-295 |
Origin Biosciences Inc | fosdenopterin hydrobromide | 73129-001 |
>Company | >Ingredient | >NDC |
fosdenopterin hydrobromide drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.